Abstract
Much effort has been dedicated in the recent decades to find novel protein/enzyme-based therapies for human diseases, the major challenge of such therapies being the intracellular delivery and reaching sub-cellular organelles. One promising approach is the use of cell-penetrating peptides (CPPs) for delivering enzymes/proteins into cells. In this review, we describe the potential therapeutic usages of CPPs (mainly trans-activator of transcription protein, TAT) in enabling the uptake of biologically active proteins/enzymes needed in cases of protein/enzyme deficiency, concentrating on mitochondrial diseases and on the import of enzymes or peptides in order to destroy pathogenic cells, focusing on cancer cells.
| Original language | English |
|---|---|
| Article number | 924 |
| Journal | Life |
| Volume | 11 |
| Issue number | 9 |
| DOIs | |
| State | Published - 6 Sep 2021 |
Bibliographical note
Publisher Copyright:© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Apoptosis
- CPPs
- Cancer
- MTS
- Mitochondrial diseases
- TAT
- TAT-ApoProtein fusion proteins
- TAT-MTS-MitoProtein fusion proteins
Fingerprint
Dive into the research topics of 'Tat for enzyme/protein delivery to restore or destroy cell activity in human diseases'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver